Avantis vs Bio Protocol — how do they compare? Avantis trades at Rp1,798 (market cap Rp598,73M, Rp1,4T 24h volume), while Bio Protocol trades at Rp435.16 (market cap Rp986,63M, Rp162,5M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Avantis's circulating supply is 338,9M / 1B AVNT (34%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Avantis for 22 Days and Bio Protocol for 18 Days on average.
| AVNT | BIO | |
|---|---|---|
Market Cap | Rp598,73M | Rp986,63M |
Volume (24h) | Rp1,4T | Rp162,5M |
Circulating Supply | 338,9M / 1B AVNT (34%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 22 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
Avantis (AVNT) is trading at Rp1,957 with a market cap of Rp647.99M, showing bullish technical signals across moving averages and oscillators. The token is currently trading near its pivot point of Rp1,875 with strong support at Rp1,676 and resistance at Rp2,133. With 34% of the 1M max supply in circulation and an average hold time of 22 days, the token demonstrates moderate distribution and holding patterns.
Overall outlook remains cautiously optimistic with technical indicators supporting bullish momentum, though RSI levels above 80 suggest potential overbought conditions. Key opportunities include continued technical strength and network growth, while risks include high volatility and regulatory uncertainty typical of cryptocurrency assets.
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
What Pluang investors did over the last 30 days
Avantis is the largest RWA perpetuals DEX in DeFi, built on Base. It enables users to trade crypto and real-world assets such as FX, commodities, indices, and equities. Supported by Pantera and Coinbase, Avantis combines institutional-grade products with the transparency and accessibility of DeFi, offering leverage up to 500x.
Read more on AVNT →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →